Cataract surgeons Alan Faulkner, M.D. and Tyrie Jenkins, M.D. have made the procedure safer for patients at The Surgical Suites with a new added technology.

Dr. Jenkins and Dr. Faulkner are one of the first surgeons in the United States to gain access to and training for the miLOOP™, a micro-interventional device that employs a super elastic filament that retains shape memory.  The substance, Nitinol, has been used in the past for radiology and cardiovascular procedures. 

The cataract is broken up by miLOOP™, a pen-like device that has a loop snare of nitinol filament that is maneuvered around the lens. The procedure reduces the amount of ultrasonic energy, and puts less stress on the the eye.  It also has better postoperative results, as it reduces the chances of damage to the cornea.

“We are impressed with how simple and intuitive the device is to use,” said Dr. Faulkner. “We anticipate that it will improve outcomes, and increase the safety and efficiency of cataract surgery.”  

The device was invented by ophthalmologist Sean Ianchulev, M.D. MPH, a Harvard-trained professor at New York Eye and Ear, Icahn School of Medicine.  It received FDA clearance and became commercially available in 2017.

“The miLOOP™ is gentler on the eye; I look forward to using it to help my Hawaii patients as well as those I serve in the global community when I travel on surgical missions,” added Dr. Jenkins. 

The miLOOP™ is designed to be a one-time use device; it is easily transportable, and can be used in places where the same level of care is not accessible.  It is also being used to bolster larger efforts, treating preventable blindness from cataracts around the world.